Welcome to our dedicated page for Olaplex Holdings SEC filings (Ticker: OLPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Olaplex’s patents and bond-building chemistry sit at the core of every SEC disclosure. Whether you’re comparing salon versus retail revenue or checking how a single proprietary ingredient affects margins, the details live inside each report. Investors often ask, “Where can I read an Olaplex annual report 10-K simplified?� or “How do I track Olaplex insider trading Form 4 transactions?”—this page answers both.
Stock Titan’s AI turns dense paperwork into clear insight. Open any Olaplex quarterly earnings report 10-Q filing and our engine highlights channel-mix shifts, inventory tied to raw materials, and regional demand trends in seconds. Need real-time alerts on Olaplex Form 4 insider transactions? You’ll receive them the moment they post. Our summaries also decode every 8-K material event explained, from supply-chain updates to litigation involving patent claims.
All filings appear the moment they hit EDGAR:
- 10-K for deep dives into IP strategy and risk factors
- 10-Q for recent sales growth and cash-flow swings
- Form 4 for Olaplex executive stock transactions Form 4 monitoring
- DEF 14A proxy statement executive compensation breakdowns
- 8-K for unplanned announcements that move the share price
On 22 July 2025 Spok Holdings (NASDAQ:SPOK) filed an Item 5.07 Form 8-K reporting the voting results of its 2025 Annual Meeting. Of 20.58 million shares entitled to vote, 16.16 million (�78.5%) were represented by proxy.
- Director elections: All six nominees—Bobbie Byrne, Christine Cournoyer, Randy Hyun, Vincent Kelly, Brett Shockley and Todd Stein—were re-elected with 96.6-98.0% of votes cast.
- Auditor ratification: Grant Thornton LLP was confirmed as independent registered public accounting firm for FY-2025 with 97.7% support (15,718,526 for vs. 380,180 against).
- Say-on-Pay: The advisory resolution on named executive officer compensation passed with 95.3% support (12,111,357 for vs. 476,088 against).
No other business was conducted, and there were no broker non-votes on the auditor item. These routine governance outcomes do not alter the company’s operational or financial outlook.
Olaplex (NASDAQ: OLPX) filed a routine Form 4 on June 29, 2025. The filing states that former director Paula Zusi ceased serving on the board effective June 10, 2025 and is therefore no longer subject to Section 16 reporting requirements. No purchases, sales, or other equity transactions were disclosed, and the tables for both non-derivative and derivative securities list no entries. The document is filed voluntarily to formally register Ms. Zusi’s change in reporting status.
Because the Form 4 reports no share transactions or monetary amounts, it represents an administrative update rather than a market-moving event.